ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.00%
      US Tech 100
      16,882.40
      -1.04%
      Dow Jones
      38,460.92
      0.00%
      Brent Oil
      87.30
      0.09%
      Bitcoin
      63,850.80
      -0.66%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Syndax Pharmaceuticals Inc (SNDX)

      7. Syndax Pharmaceuticals Inc (SNDX) News

      SNDX Syndax Pharmaceuticals Inc

      20.79
      0.00 (0.00%)
      Pre Market
      Last Updated: 07:00:00
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Syndax Pharmaceuticals Inc SNDX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 20.79 07:00:00
      Open Price Low Price High Price Close Price Prev Close
      20.79
      more quote information »

      Recent News

      Date Time Source Heading
      4/10/202416:05PRNUSSyndax Announces Participation at the Stifel 2024 Virtual..
      4/08/202407:00PRNUSSyndax Presents Positive Pediatric Data from Pivotal..
      4/05/202416:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
      3/28/202407:00PRNUSSyndax Announces Completion of Enrollment in AUGMENT-101..
      3/26/202416:05PRNUSSyndax Announces FDA Priority Review of NDA for Revumenib..
      3/18/202407:00PRNUSSyndax Announces Appointment of Steven Closter as Chief..
      3/01/202416:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
      2/27/202417:28EDGAR2Form S-3ASR - Automatic shelf registration statement of..
      2/27/202417:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
      2/27/202416:05PRNUSSyndax Pharmaceuticals Reports Fourth Quarter and Full Year..
      2/27/202416:03EDGAR2Form 8-K - Current report
      2/26/202407:00PRNUSSyndax Announces Participation at Two Upcoming Investor..
      2/20/202416:05PRNUSSyndax to Announce Fourth Quarter and Year-end 2023..
      2/14/202412:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      2/14/202407:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/13/202421:44EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/09/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/09/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/09/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/09/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/09/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/09/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/09/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202416:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
      2/01/202416:10PRNUSSyndax Announces Participation at Two Upcoming Investor..
      1/05/202416:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
      1/02/202416:05PRNUSSyndax Announces Presentation at 42nd Annual J.P. Morgan..
      1/02/202407:00PRNUSSyndax Highlights Recent Updates and Anticipated 2024..
      12/20/202308:40EDGAR2Form 8-K - Current report
      12/19/202316:16PRNUSSyndax Announces Closing of Public Offering of Common Stock..
      12/15/202317:29EDGAR2Form 8-K - Current report
      12/15/202317:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      12/14/202323:07PRNUSSyndax Announces Pricing of $200 Million Public Offering of..
      12/14/202316:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      12/14/202316:00PRNUSSyndax Announces Proposed $150 Million Public Offering of..
      12/12/202316:05EDGAR2Form 8-K - Current report
      12/12/202312:00PRNUSSyndax Presents Positive Data from Pivotal AUGMENT-101 Trial..
      12/11/202307:30PRNUSSyndax Announces Positive Data for Revumenib in Patients..
      12/11/202306:33BWIncyte und Syndax präsentieren bei ASH-Plenarsitzung weitere..
      12/10/202317:00BWIncyte and Syndax Present Additional Data from Positive..
      12/04/202307:00PRNUSSyndax to Host Investor Event to Discuss Axatilimab and..
      12/01/202316:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
      11/21/202309:00PRNUSSyndax Announces Data from Pivotal AUGMENT-101 Trial of..
      11/07/202307:00PRNUSSyndax Announces Participation at Stifel Healthcare..
      11/03/202316:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
      11/02/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/02/202316:05PRNUSSyndax Pharmaceuticals Reports Third Quarter 2023 Financial..
      11/02/202316:03EDGAR2Form 8-K - Current report
      11/02/202309:00PRNUSSyndax Announces Results from the Pivotal AGAVE-201 Trial of..
      10/31/202316:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..

      Your Recent History

      NASDAQ
      SNDX
      Syndax Pharmaceuticals
      Delayed Upgrade Clock